S&P Global (SPGI) shares slumped 9% after the company's Q4 adjusted earnings, reported Tuesday, missed analysts' expectations, while its 2026 adjusted earnings outlook came in below consensus.

More than 8.29 million shares of the company traded intraday compared with a daily average of about 1.8 million.

CFRA, an independent research provider, said it views Xylem's (XYL) 2026 guidance as disappointing, with consensus expectations at the absolute top end of the EPS range.

Management guided for 2026 EPS growth of 5%-8% with revenue of $9.1 billion to $9.2 billion (over 2% to 4% organic growth), according to CFRA. The modest revenue outlook implies potential issues with backlog execution and timing, suggesting more measured growth than originally anticipated, CFRA said.

Shares of Xylem dropped 8%, with intraday trading volume rising to over 2.55 million from a daily average of roughly 1.41 million.

Price: 404.68, Change: -39.52, Percent Change: -8.90